Debrisoquine is a synthetic 2(1H)-isoquinolinecarboximidamide derivative and guanidine derivative historically utilized as a pharmacological probe to phenotype individuals based on the activity of the… Read more






Debrisoquine is a synthetic 2(1H)-isoquinolinecarboximidamide derivative and guanidine derivative historically utilized as a pharmacological probe to phenotype individuals based on the activity of the CYP2D6 drug-metabolizing enzyme. This category encompasses a comprehensive range of reference standards, including the active pharmaceutical ingredient, its identified pharmacopeial and non-pharmacopeial impurities such as 4-hydroxydebrisoquine, and stable isotope-labelled compounds. Pharmaceutical and analytical laboratories utilize these high-quality materials for impurity profiling, method validation, and quantitative analysis. Stable isotope-labelled analogues are particularly valuable as internal standards in mass spectrometry workflows, ensuring accuracy and precision in the quality control of debrisoquine-related drug products and metabolic studies. By providing essential materials for characterizing the metabolic pathway and purity of the parent substance, these compounds support rigorous investigative research and regulatory compliance in pharmaceutical development.